Two sirtuins of interest for targeted cancer therapy include SIRT1 and SIRT2, which deacetylate histones H3, H4, and nonhistone substrates, playing a key role in DNA repair and oxidative stress mitigation [20,21]. The gene discussed is SIRT1; the disease is cancer.